Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08 févr. 2024 09h55 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 févr. 2024 13h43 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
06 févr. 2024 02h20 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 February 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion will be initiated on 6 February 2024. As part of this, Novo...
Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction
05 févr. 2024 06h04 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 5 February 2024 – Novo Nordisk today announced that the company has agreed to acquire three fill-finish sites from Novo Holdings A/S (Novo Holdings) in connection with a transaction...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
01 févr. 2024 14h51 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk files annual report with the SEC
31 janv. 2024 07h34 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 31 January 2024 – Novo Nordisk A/S has filed its Annual Report 2023 on Form 20-F for the financial year 2023 with the US Securities and Exchange Commission (SEC), incorporating by...
Novo Nordisk's sales increased by 31% in Danish kroner and by 36% at constant exchange rates to DKK 232.3 billion in 2023
31 janv. 2024 01h30 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 31 January 2024 - Financial report for the period 1 January 2023 to 31 December 2023 ...
Novo Nordisk A/S - share repurchase programme
30 janv. 2024 10h28 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 30 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
22 janv. 2024 07h01 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
15 janv. 2024 05h43 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...